首页|In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compounds
In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compounds
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Resiquimod (R-848) is an immune response modifier activating toll-like receptor 7 and 8. Its potential to cause pharmacokinetic interactions with concurrently administered drugs is unknown.
ResiquimodNuclear factor kappa BPregnane x receptorPharmacokinetic interactionsDrug transporter
Theile, Dirk、Wagner, Lelia、Haefeli, Walter E.、Weiss, Johanna
NSTL
Elsevier
